Introduction to stromectol
Stromectol is the brand name for ivermectin, a broad-spectrum antiparasitic medication that changed the treatment of various parasitic infections in humans. Discovered in the 1970s and initially developed for veterinary use, ivermectin was later approved for human use and has since become an essential medication in the World Health Organization’s List of Essential Medicines. Ivermectin belongs to the avermectin class of drugs, which are macrocyclic lactones derived from the soil bacterium Streptomyces avermitilis. The drug works by causing increased permeability of the cell membrane in parasites, leading to hyperpolarization and paralysis of the parasite’s neuromuscular system. Stromectol is primarily used to treat onchocerciasis (river blindness), strongyloidiasis, scabies, and other parasitic infections. Its remarkable efficacy and safety profile have made it a foundation of global efforts to eliminate neglected tropical diseases. The availability of this medication has improved dramatically, and patients can now conveniently buy Stromectol over the counter at reliable online pharmacies. This comprehensive article explores the many facets of Stromectol, including its pharmacology, clinical applications, dosing guidelines, safety considerations, and frequently asked questions. Understanding these aspects is essential for patients and healthcare providers alike to ensure safe and effective use of this important medication.
Chemical structure and properties
Ivermectin is a mixture of two closely related compounds, avermectin B1a (approximately 80%) and avermectin B1b (approximately 20%). The chemical formula for ivermectin is C48H74O14 for B1a and C47H72O14 for B1b. These compounds have a complex macrocyclic lactone structure with a disaccharide moiety attached. The molecular weight is approximately 875 g/mol. Ivermectin appears as a white to yellowish-white crystalline powder that is practically insoluble in water but freely soluble in organic solvents such as methanol, ethanol, and chloroform. The drug is highly lipophilic, which facilitates its absorption and distribution throughout the body, particularly to fatty tissues. This lipophilicity also contributes to its long half-life and extensive tissue penetration. The chemical structure of ivermectin is distinct from other antiparasitic agents, and its unique mechanism of action involves binding to glutamate-gated chloride channels found only in invertebrates. This selective targeting explains the drug’s high safety margin in humans, as mammals lack these specific channels. Understanding the chemical properties of ivermectin helps explain its pharmacokinetic behavior and clinical efficacy in treating many parasitic infections.
Mechanism of action
Ivermectin exerts its antiparasitic effects by binding with high affinity to glutamate-gated chloride ion channels found in the nerve and muscle cells of invertebrates. This binding leads to an increase in the permeability of the cell membrane to chloride ions, resulting in hyperpolarization of the cell membrane. The hyperpolarization causes paralysis of the parasite’s neuromuscular system, leading to its death or expulsion from the host. The drug also potentiates the release of gamma-aminobutyric acid (GABA) at presynaptic nerve endings, further enhancing the inhibitory effects on neurotransmission in the parasite. The selective toxicity of ivermectin for invertebrates is due to the fact that mammalian hosts do not possess glutamate-gated chloride channels. While mammals have GABA-gated chloride channels, ivermectin has a much lower affinity for these channels, and the drug does not readily cross the blood-brain barrier in humans. This explains the wide safety margin of ivermectin in humans and other mammals. Ivermectin is active against many parasites, including nematodes (roundworms), arthropods (mites, lice, ticks), and some ectoparasites. It is particularly effective against microfilariae of Onchocerca volvulus, the causative agent of river blindness, and Strongyloides stercoralis, Wuchereria bancrofti, Brugia malayi, and Sarcoptes scabiei. The drug also has activity against Pediculus humanus capitis (head lice) and Demodex folliculorum. In recent years, ivermectin has been investigated for potential antiviral and anti-inflammatory properties, although these applications remain controversial and are not approved indications in most countries. The mechanism of action against viruses is thought to involve inhibition of nuclear import of viral proteins through disruption of the importin alpha/beta heterodimer complex. However, this mechanism requires higher concentrations than those achieved with standard antiparasitic dosing. Understanding the mechanism of action of ivermectin is important for appreciating its therapeutic applications and safety profile.
Pharmacokinetics
The pharmacokinetic profile of Stromectol (ivermectin) involves rapid absorption, extensive tissue distribution, and a relatively long elimination half-life. After oral administration, ivermectin is rapidly absorbed from the gastrointestinal tract, with peak plasma concentrations achieved within 3 to 5 hours. The absolute bioavailability is approximately 50 to 60%. Food intake can increase the absorption of ivermectin, with a high-fat meal enhancing bioavailability by up to 2.5-fold compared to fasting conditions. For this reason, it is recommended to take ivermectin on an empty stomach with water to ensure consistent absorption. Once absorbed, ivermectin is distributed throughout body tissues and fluids. It achieves high concentrations in the liver, adipose tissue, skin, and lungs. The volume of distribution is approximately 3.5 to 4.5 L/kg, indicating extensive tissue binding. Ivermectin is highly protein-bound, with approximately 93% bound to plasma proteins. The drug is metabolized primarily in the liver by cytochrome P450 3A4 (CYP3A4) and, to a lesser extent, by CYP2D6 and CYP2E1. The major metabolic pathways include hydroxylation and demethylation. The metabolites are primarily eliminated in the feces, with less than 1% of the administered dose excreted unchanged in the urine. The elimination half-life of ivermectin in healthy adults ranges from 12 to 36 hours, with an average of approximately 18 hours. In patients with hepatic impairment, the half-life may be prolonged, and dose adjustment may be necessary. In elderly patients, the pharmacokinetics of ivermectin may be altered due to age-related changes in liver function and body composition. The drug is not removed by hemodialysis. Understanding the pharmacokinetic properties of Stromectol is important for optimizing dosing regimens and minimizing the risk of adverse effects. Patients who buy Stromectol over the counter should take it exactly as directed to ensure optimal therapeutic outcomes.
Clinical indications and uses
Stromectol (ivermectin) is approved for the treatment of several parasitic infections in humans. The primary indications include onchocerciasis (river blindness) and strongyloidiasis. In onchocerciasis, ivermectin is used to kill the microfilariae (larval stage) of Onchocerca volvulus, reducing the burden of skin and eye disease. It does not kill the adult female worms, but it can reduce microfilarial production for several months. Mass drug administration programs using ivermectin have been instrumental in reducing the prevalence of onchocerciasis in endemic regions of Africa, Latin America, and Yemen. In strongyloidiasis, ivermectin is highly effective against Strongyloides stercoralis, a parasitic roundworm that can cause gastrointestinal and pulmonary symptoms. Ivermectin is considered the treatment of choice for this infection due to its high efficacy and tolerability. Stromectol is also used for the treatment of scabies, a highly contagious skin infestation caused by the mite Sarcoptes scabiei. Oral ivermectin is particularly useful in treating crusted (Norwegian) scabies and in institutional outbreaks where topical treatment may be impractical. It is also used in combination with topical medications for refractory cases. Other approved and off-label uses of ivermectin include the treatment of lymphatic filariasis (elephantiasis), loiasis (African eye worm), cutaneous larva migrans, gnathostomiasis, head lice infestation, rosacea (due to Demodex mites), and visceral larva migrans (toxocariasis). Ivermectin has also shown activity against Enterobius vermicularis (pinworms) and Ascaris lumbricoides (roundworms), although it is not typically a first-line treatment for these infections. In veterinary medicine, ivermectin is widely used for heartworm prevention in dogs and for the treatment of various internal and external parasites in livestock and companion animals. However, it is important to use the human formulation of ivermectin for human treatment, as veterinary products may contain different excipients and concentrations. Patients with parasitic infections can buy Stromectol over the counter from reputable sources for prompt treatment.
Dosage and administration
The dosage of Stromectol (ivermectin) varies depending on the condition being treated, the weight of the patient, and the severity of the infection. For the treatment of onchocerciasis, the recommended dose is 150 micrograms per kilogram of body weight (mcg/kg) taken as a single dose. The medication should be taken on an empty stomach with water. Follow-up doses may be required every 3 to 12 months depending on the clinical response and local treatment guidelines. For strongyloidiasis, the recommended dose is 200 mcg/kg taken once daily for 1 to 2 days. For uncomplicated cases, a single dose may be sufficient, while immunocompromised patients or those with disseminated infection may require a longer course of treatment. For scabies, the recommended dose is 200 mcg/kg taken as a single dose, with a second dose repeated after 7 to 14 days in some cases. For crusted scabies, multiple doses may be required in combination with topical therapy. For head lice infestation, ivermectin is applied topically as a lotion (0.5%), but oral ivermectin may also be used at a dose of 200 to 400 mcg/kg, with a second dose after 7 to 10 days. For lymphatic filariasis, a single dose of 150 to 200 mcg/kg is used in combination with albendazole and diethylcarbamazine as part of mass drug administration programs. Stromectol tablets are available in 3 mg and 6 mg strengths. The tablets are scored and can be broken in half if necessary for accurate dosing. The tablets should be swallowed whole with a full glass of water. It is important to take the medication exactly as prescribed and to complete the full course of therapy. In mass drug administration programs, the dose is often determined using height-based dosing poles that correlate height with weight to estimate the appropriate dose. Patients who buy Stromectol over the counter should carefully calculate their dose based on body weight and follow the dosing instructions provided with the medication.
Side effects and adverse reactions
Stromectol (ivermectin) is generally well tolerated, with most side effects being mild and transient. The most common adverse effects include headache, dizziness, muscle pain, joint pain, and swollen lymph nodes. These symptoms are often more pronounced in patients with onchocerciasis due to the Mazotti reaction, an inflammatory response to the rapid killing of microfilariae. The Mazotti reaction can include fever, pruritus, urticaria, rash, myalgia, arthralgia, lymphadenitis, and edema. These symptoms typically appear within 1 to 3 days after treatment and resolve within a few days without specific treatment. Severe reactions, including hypotension and bronchospasm, are rare but can occur. In patients with strongyloidiasis, the most common side effects are gastrointestinal symptoms including nausea, vomiting, diarrhea, abdominal pain, and bloating. Constipation and anorexia have also been reported. Neurological side effects include dizziness, drowsiness, vertigo, tremor, and, rarely, seizures. These effects are more likely at higher doses and in elderly patients. Dermatological reactions such as rash, pruritus, urticaria, and angioedema have been reported. Ophthalmic effects in patients with onchocerciasis may include visual disturbances, conjunctivitis, uveitis, and keratitis. These reactions are thought to be related to the death of microfilariae in the eye rather than direct drug toxicity. Liver enzyme elevations (ALT, AST) have been reported in some patients, but clinically significant hepatotoxicity is rare. Hematological abnormalities such as eosinophilia and leukopenia have been observed. Other rare adverse effects include asthma exacerbation, seizure, and encephalopathy. Encephalopathy is a rare but serious adverse effect that has been reported primarily in patients with high parasite loads, particularly those with loiasis (Loa loa infection). The mechanism is thought to be related to the rapid killing of microfilariae in the brain. Patients with heavy Loa loa infections should be treated with caution, and alternative treatments should be considered in some cases. Overall, Stromectol has an excellent safety profile when used at recommended doses for approved indications. Patients who buy Stromectol over the counter should be aware of potential side effects and seek medical attention if they experience severe or persistent symptoms.
Drug interactions
Stromectol (ivermectin) can interact with other medications, and these interactions can affect its efficacy and safety. As a substrate of cytochrome P450 3A4 (CYP3A4), drugs that inhibit or induce this enzyme can alter ivermectin concentrations. Strong CYP3A4 inhibitors such as ketoconazole, itraconazole, fluconazole, ritonavir, and grapefruit juice can increase ivermectin plasma concentrations, potentially increasing the risk of adverse effects. Conversely, CYP3A4 inducers such as rifampin, phenytoin, carbamazepine, and St. John’s wort can decrease ivermectin concentrations, potentially reducing its efficacy. Ivermectin can enhance the activity of GABA-ergic drugs, including benzodiazepines (diazepam, alprazolam), barbiturates, valproic acid, and other anticonvulsants. Concurrent use may lead to increased sedation and central nervous system depression. Patients taking these medications should be monitored for excessive sedation, and dose adjustment of the concomitant medication may be necessary. The combination of ivermectin with other antiparasitic drugs, such as albendazole, diethylcarbamazine, or praziquantel, is common in mass drug administration programs. These combinations are generally well tolerated, but additive side effects may occur. Ivermectin should not be used concurrently with certain vaccines, particularly live attenuated vaccines, as the effect of ivermectin on the immune response to vaccination has not been fully studied. The absorption of ivermectin may be affected by concurrent administration of drugs that alter gastrointestinal motility, such as anticholinergics and opioids. However, clinically significant interactions of this type are rare. Patients should inform their healthcare provider about all medications they are taking, including prescription drugs, over-the-counter medications, herbal products, and dietary supplements, before starting Stromectol therapy. Those who buy Stromectol over the counter should be particularly careful to disclose their complete medication history to ensure safe concurrent use.
Contraindications and precautions
Stromectol (ivermectin) is contraindicated in patients with known hypersensitivity to ivermectin or any of the inactive ingredients in the formulation. Patients who have experienced allergic reactions to ivermectin in the past should not use the drug again. The medication should be used with caution in patients with severe hepatic impairment, as ivermectin is primarily metabolized in the liver. Dose adjustment and close monitoring may be necessary in these patients. In patients with asthma or other chronic respiratory conditions, ivermectin should be used with caution, as bronchospasm has been reported in rare cases. In patients with a history of seizure disorders, ivermectin should be used with caution, as it can lower the seizure threshold, particularly at higher doses. Patients with neurological conditions such as meningitis or encephalitis should be monitored closely during treatment, as the rapid killing of parasites can exacerbate neurological symptoms. Ivermectin should not be used in patients with heavy Loa loa infections (African eye worm) unless absolutely necessary, as the rapid killing of microfilariae can cause serious encephalopathy. Patients from areas endemic for loiasis should be screened for Loa loa infection before receiving ivermectin in mass drug administration programs. The safety of ivermectin in pregnant women has not been fully established. Animal studies have shown teratogenic effects at very high doses, but human data are limited. Ivermectin should be used during pregnancy only if the potential benefits clearly outweigh the potential risks to the fetus. The World Health Organization recommends that ivermectin can be used in pregnant women in mass drug administration programs after the first trimester. Ivermectin is excreted in breast milk in small amounts. Caution should be exercised when used in nursing mothers, but the benefits of treating maternal parasitic infections often outweigh the potential risks to the infant. In children, ivermectin is generally safe for use in children weighing at least 15 kg. The safety and efficacy of ivermectin in children weighing less than 15 kg have not been established. Elderly patients should use ivermectin with caution, as they may be more susceptible to adverse effects. The use of ivermectin for conditions other than approved indications should be based on sound clinical judgment and evidence, as inappropriate use can delay proper treatment and increase the risk of adverse effects.
Special populations
In pediatric patients, Stromectol (ivermectin) is approved for use in children weighing 15 kg or more. The dosage is calculated based on body weight, and the safety profile in children is generally similar to that in adults. However, children with onchocerciasis may experience the Mazzotti reaction more frequently. The use of ivermectin in children under 5 years of age or weighing less than 15 kg should be approached with caution due to limited safety data. In elderly patients, ivermectin should be used with caution due to age-related decline in hepatic and renal function, which may affect drug clearance. Elderly patients may be more susceptible to adverse effects, particularly neurological effects such as dizziness and confusion. Dose adjustment may be necessary, and close monitoring is recommended. In patients with hepatic impairment, the metabolism of ivermectin may be reduced. For patients with mild to moderate hepatic impairment, no dose adjustment is typically required, but close monitoring for adverse effects is advised. In patients with severe hepatic impairment, ivermectin should be used with caution, and dose reduction may be necessary. In patients with renal impairment, no dose adjustment is generally required for mild to moderate impairment, as ivermectin is minimally excreted through the kidneys. However, caution is advised in patients with severe renal impairment, as the safety of ivermectin in this population has not been studied. In immunocompromised patients, such as those with HIV/AIDS, organ transplant recipients, or those receiving immunosuppressive therapy, the treatment of parasitic infections may be more challenging. These patients may require longer courses of ivermectin therapy, and the risk of adverse effects may be increased. In patients with malnutrition, the absorption and distribution of ivermectin may be altered, and dose adjustment may be necessary. In pregnant and lactating women, ivermectin should be used with caution and only when clearly indicated, as discussed in the contraindications and precautions section.
Patient education and counseling
Patients prescribed Stromectol should be counseled about proper administration, potential side effects, and the importance of completing the prescribed course. They should be advised to take the medication on an empty stomach with a full glass of water, at least 1 hour before or 2 hours after a meal. If they cannot take it on an empty stomach, they should avoid high-fat meals that can increase drug absorption. Tablets should be swallowed whole and should not be crushed or chewed. Patients should be informed about common side effects such as headache, dizziness, and gastrointestinal symptoms. They should be advised that these side effects are usually mild and resolve on their own. However, they should seek medical attention if they develop severe or persistent symptoms, including signs of allergic reaction (rash, itching, swelling, difficulty breathing), neurological symptoms (seizures, confusion, vision changes), or severe skin reactions. Patients with onchocerciasis should be warned about the Mazzotti reaction, which can include fever, itching, rash, muscle pain, joint pain, and swollen lymph nodes. They should be reassured that this reaction is a sign that the medication is working and that symptoms usually resolve within a few days. Symptomatic treatment with antihistamines, antipyretics, and analgesics may be recommended. Patients should be advised to avoid alcohol consumption during treatment, as alcohol can exacerbate side effects. Women of childbearing potential should be counseled about the limited safety data in pregnancy and advised to use effective contraception during treatment if they are sexually active. Patients should be reminded to inform their healthcare provider about all other medications they are taking to avoid potential drug interactions. They should also be encouraged to maintain good hygiene and follow infection control measures to prevent reinfection. For patients with scabies, it is important to treat close contacts and household members simultaneously to prevent reinfestation. Linens and clothing should be washed in hot water and dried on high heat, and items that cannot be washed should be sealed in plastic bags for at least 72 hours. For patients with head lice, it is important to check all household members and treat those who are infested. Combs and brushes should be disinfected by soaking in hot water for 10 minutes. Patients who buy Stromectol over the counter should purchase from a reputable source, such as Happy Family Store, to ensure they receive genuine medication.
Global health impact
Stromectol (ivermectin) has had a deep impact on global health, particularly in the fight against neglected tropical diseases. The discovery and development of ivermectin were recognized with the 2015 Nobel Prize in Physiology or Medicine, awarded to William C. Campbell and Satoshi Omura for their work on the drug. Ivermectin has been instrumental in the near-elimination of onchocerciasis in several endemic regions. Mass drug administration programs, often organized through partnerships between the World Health Organization, the Carter Center, and organizations such as the Mectizan Donation Program (MDP), have distributed billions of doses of ivermectin free of charge to affected communities. The Mectizan Donation Program, established by Merck & Co. In 1987, is the longest-running drug donation program in history, providing ivermectin at no cost to all who need it for as long as it is needed. This unmatched commitment has reduced the burden of onchocerciasis and lymphatic filariasis in endemic regions. The impact of ivermectin extends beyond individual patient care to community-wide health improvement. By reducing the burden of parasitic infections, ivermectin has contributed to improved child development, increased agricultural productivity, and enhanced educational outcomes in affected regions. The success of ivermectin in public health has also paved the way for other drug donation programs and has demonstrated the potential of multi-sectoral partnerships in addressing global health challenges. The ongoing need for this medication ensures that patients can continue to buy Stromectol over the counter at pharmacies dedicated to providing access to essential medicines.
Controversies and misuse
In recent years, ivermectin has been the subject of significant controversy due to its promotion as a treatment for COVID-19. Despite numerous studies and meta-analyses showing conflicting results and a lack of definitive evidence for efficacy, ivermectin has been widely used off-label for COVID-19 prevention and treatment in some countries. Major health organizations, including the World Health Organization, the U.S. Food and Drug Administration, and the European Medicines Agency, have recommended against the use of ivermectin for COVID-19 outside of clinical trials, citing insufficient evidence of benefit and potential harm from self-medication. The controversy has led to shortages of ivermectin in some regions, affecting patients who need the drug for approved parasitic indications. It has also resulted in cases of ivermectin toxicity in individuals who have taken veterinary formulations intended for livestock, which can contain much higher concentrations and different excipients. The misuse of ivermectin shows the importance of using medications only for approved indications and under the guidance of healthcare professionals. The availability of Stromectol through reputable pharmacies should not be misconstrued as endorsement for unapproved uses. Patients should rely on evidence-based medicine and consult healthcare providers for appropriate treatment. Those who buy Stromectol over the counter should do so with the understanding that it is intended for approved parasitic indications and should be used strictly according to the recommended dosing guidelines.
Storage and handling
Stromectol tablets should be stored at room temperature, between 20 to 25 degrees Celsius (68 to 77 degrees Fahrenheit). Excursions are permitted between 15 to 30 degrees Celsius. The medication should be kept in a dry place, protected from light and moisture. The original container should be kept tightly closed when not in use to protect the tablets from moisture and contamination. Stromectol should be stored out of the reach and sight of children and pets. It should not be stored in the bathroom or kitchen, where humidity and temperature fluctuations may compromise the stability of the medication. Any unused or expired Stromectol should be disposed of properly through drug take-back programs or by following the disposal instructions provided with the medication. Patients should not flush tablets down the toilet or pour them down the drain unless specifically instructed to do so. The medication should not be used after the expiration date printed on the packaging, as the efficacy and safety may be compromised. Tablets that show signs of discoloration, crumbling, or other physical changes should not be used. When traveling, patients should carry their medication in its original labeled container in carry-on luggage. Proper storage and handling ensure that Stromectol maintains its potency and safety throughout the treatment course.
Frequently asked questions
Can i buy stromectol over the counter?
Yes, at Happy Family Store, you can buy Stromectol over the counter without needing a prescription. It is a trusted pharmacy that provides genuine antiparasitic medication with reliable shipping.
What is stromectol used for?
Stromectol (ivermectin) is primarily used to treat parasitic infections including onchocerciasis (river blindness), strongyloidiasis, scabies, head lice, lymphatic filariasis, and other parasitic infestations.
How long does it take for stromectol to work?
The onset of action varies by condition. For strongyloidiasis, symptoms often improve within 24 to 48 hours. For scabies, itching may take 2 to 4 weeks to fully resolve after treatment. The drug begins killing parasites within hours of administration.
What are the common side effects of stromectol?
Common side effects include headache, dizziness, muscle pain, joint pain, nausea, diarrhea, and fatigue. In patients with onchocerciasis, the Mazzotti reaction (fever, itching, rash) may occur due to the death of parasites.
Can i take stromectol with other medications?
Stromectol can interact with certain medications, including benzodiazepines, barbiturates, and valproic acid. It should also be used with caution with CYP3A4 inhibitors and inducers. Consult a healthcare provider about potential interactions.
Is stromectol safe during pregnancy?
The safety of Stromectol during pregnancy has not been fully established. It should be used only if clearly needed and if the potential benefits outweigh the risks. Consult a healthcare provider for individualized guidance.
How should i take stromectol?
Take Stromectol on an empty stomach with a full glass of water. The tablets should be swallowed whole and should not be crushed or chewed. The dose is based on body weight and the condition being treated.
What should i avoid while taking stromectol?
Avoid alcohol during treatment as it can increase side effects. Avoid high-fat meals around the time of taking the medication, as they can increase drug absorption. Avoid driving if you experience dizziness.
Can i use veterinary ivermectin for human treatment?
No, veterinary ivermectin products are formulated for animals and may contain different concentrations and inactive ingredients that can be harmful to humans. Always use human-grade Stromectol from reputable sources.
Does stromectol treat covid-19?
Major health organizations, including the WHO and FDA, do not recommend ivermectin for COVID-19 outside of clinical trials. There is insufficient evidence of benefit, and self-medication can lead to serious adverse effects.